Peptide Hormones, Metformin and New-Wave Practices and Research Therapies
Abstract
Prescription medicines are progressively being abused to augment appearance. Information gleaned from the sporting arena is being extrapolated to the domestic market merely because of the increase in obesity in the population. The list of the types of drug use and their metabolic effects is diverse and includes drugs that are believed to increase the basal metabolic rate (clenbuterol, ephedrine, recombinant human growth hormone, insulin-like growth factor-1 Long arm 3, thyroxine) prevent fat absorption (orlistat) or affect neurochemical modulators (sibutramine). Such drugs if used indiscriminately even with medical supervision, can cause serious long-term sequelae and call their use into question? These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.